Compliance with independent security standards comes as Proscia accelerates digital pathology deployments at scale PHILADELPHIA – December 3, 2025 – Proscia®, a pathology AI company, has successfully completed its SOC 2 Type II audit....

From the Proscia blog: At Access25, we brought together leaders from life sciences, diagnostics, and technology for a global virtual event dedicated to advancing precision medicine by starting where insight begins: the moment of...

Proscia: Top clinical teaching hospital is laying the foundation for AI-driven disease diagnosis and research HAARLEM, Netherlands and PHILADELPHIA – October 27, 2025 – Spaarne Gasthuis, a top clinical teaching hospital serving part of...

Proscia: Expanding the industry’s most comprehensive portfolio of AI applications  PHILADELPHIA and PARIS—October 15, 2025—Proscia®, a pathology AI company, will add AI biomarker detection for skin tissue to...

The Future of Precision Medicine Starts at the Moment of Diagnosis OCTOBER 28, 2025 | 11:30AM ET | VIRTUAL EVENT Join Access25 on October 28 to discover how Proscia is removing one of the biggest barriers to realizing precision...

Proscia: Pathologists readily embrace the shift to digital workflows LEXINGTON, KY and PHILADELPHIA, PA – September 30, 2025  – Pathology & Cytology Laboratories (P&C Labs), a nationally recognized leader in pathology...